Navigation Links
Synergetics USA Announces Conference Call
Date:4/28/2010

O'FALLON, Mo., April  28 /PRNewswire-FirstCall/ -- Synergetics USA, Inc., (Nasdaq: SURG) will provide an online, real-time webcast and broadcast of its conference call on Wednesday, April 28, 2010, covering the settlement and license agreement with Alcon.

The live broadcast of Synergetics USA conference call will be available on-line at: http://www.synergeticsusa.com on April 28, 2010, beginning at 12:00 p.m. (Eastern Time).  The online replay will follow immediately and continue for 30 days.  To hear the Company's conference call live, dial 888-811-5448, confirmation code 7150418.  A replay will be available from 2:00 p.m. (Eastern Time) on April 28 until 11:00 p.m. (Eastern Time) on May 5.  To listen to the playback, call 7194570820, confirmation code 7150418.

About Synergetics USA, Inc.

Through continuous improvement and development of our people, our mission is to design, manufacture and market innovative microsurgical instruments, capital equipment, accessories and disposables of the highest quality in order to assist and enable surgeons who perform microsurgery around the world to provide a better quality of life for their patients.  

Synergetics USA, Inc. (the "Company") is a leading supplier of precision microsurgery instrumentation.  The Company's primary focus is on the microsurgical disciplines of ophthalmology and neurosurgery. Our distribution channels include a combination of direct and independent sales organizations and important strategic alliances with market leaders.  The Company's product lines focus upon precision engineered, microsurgical, hand-held instruments and the delivery of various energy modalities for the performance of less invasive microsurgery including:  (i) laser energy, (ii) ultrasonic energy, (iii) radio frequency for electrosurgery and oblation and (iv) visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field.  The Company's website address is http://www.synergeticsusa.com.

Forward-Looking Statements

Some statements in this release may be "forward-looking statements" for the purposes of the Private Securities Litigation Reform Act of 1995.  In some cases forward-looking statements can be identified by words such as "believe," "expect," "anticipate," "plan," "potential," "continue" or similar expressions.  Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.  These factors, risks and uncertainties are discussed in the Company's Annual Report on Form 10-K for the year ended July 31, 2009, as updated from time to time in our filings with the Securities and Exchange Commission.  The Company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.


'/>"/>
SOURCE Synergetics USA, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Roche Announces Joint Initiative to Train Healthcare Workers in Africas Fight Against Cancer
2. Perrigo Company Announces Quarterly Dividend
3. Onyx Pharmaceuticals Announces First Quarter 2010 Financial Results Teleconference and Webcast
4. ATS Medical Announces Participation in the 90th Annual Meeting of the American Association for Thoracic Surgeons
5. Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan
6. B. Braun Renal Therapies Division Announces Availability of Adimea
7. RedVision Announces Integrated Client Workflow Platform: TitleVision2 The Power of Two
8. Sangamo BioSciences Announces First Quarter 2010 Conference Call and Webcast
9. Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes
10. Samplify Announces Ultrasound Reference Design
11. PolyTouch Medical Ltd. Announces the Appointment of Karl A. LeBlanc, MD, MBA, FACS as Medical Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
Breaking Medicine News(10 mins):